483
Eugia SEZ Private LimitedEugia SEZ Private Limited – FDA 483, May 4, 2018
Record Details
Aurobindo Pharma Limited, an injectable manufacturer in Mahabubnagar District, India, was cited for significant deficiencies during an FDA inspection. Observations included a failure to thoroughly investigate product discrepancies, inadequate cleaning and disinfection procedures in aseptic processing areas, and insufficient employee training for critical operations. These issues indicate a lack of robust quality control and aseptic practices.
View Company Profile
ID · 9d6255cf-d0c7-42ab-8453-18416bd4cf5b
Other documents for Eugia SEZ Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.